Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
174.83
+0.71 (0.41%)
At close: Jan 28, 2026, 4:00 PM EST
173.00
-1.83 (-1.05%)
After-hours: Jan 28, 2026, 7:23 PM EST

Biogen Revenue

Biogen had revenue of $2.53B in the quarter ending September 30, 2025, with 2.79% growth. This brings the company's revenue in the last twelve months to $10.07B, up 4.77% year-over-year. In the year 2024, Biogen had annual revenue of $9.68B, down -1.62%.

Revenue (ttm)
$10.07B
Revenue Growth
+4.77%
P/S Ratio
2.54
Revenue / Employee
$1,323,590
Employees
7,605
Market Cap
25.65B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20249.68B-159.70M-1.62%
Dec 31, 20239.84B-337.80M-3.32%
Dec 31, 202210.17B-808.30M-7.36%
Dec 31, 202110.98B-2.46B-18.32%
Dec 31, 202013.44B-933.30M-6.49%
Dec 31, 201914.38B925.00M6.88%
Dec 31, 201813.45B1.18B9.61%
Dec 31, 201712.27B825.10M7.21%
Dec 31, 201611.45B685.00M6.36%
Dec 31, 201510.76B1.06B10.93%
Dec 31, 20149.70B2.77B39.97%
Dec 31, 20136.93B1.42B25.66%
Dec 31, 20125.52B467.83M9.27%
Dec 31, 20115.05B332.21M7.04%
Dec 31, 20104.72B339.08M7.75%
Dec 31, 20094.38B279.84M6.83%
Dec 31, 20084.10B925.89M29.19%
Dec 31, 20073.17B488.57M18.21%
Dec 31, 20062.68B260.55M10.76%
Dec 31, 20052.42B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Merck & Co.64.24B
Pfizer62.79B
Novartis AG56.37B
Sanofi53.89B
Novo Nordisk49.58B
Bristol-Myers Squibb Company48.03B
GSK plc43.24B
Amgen35.97B
Revenue Rankings